336 related articles for article (PubMed ID: 27070488)
1. Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt-Koyanagi-Harada Disease.
Chee SP; Chan SN; Jap A
Ocul Immunol Inflamm; 2017 Aug; 25(4):528-532. PubMed ID: 27070488
[TBL] [Abstract][Full Text] [Related]
2. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
Jap A; Chee SP
Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
[TBL] [Abstract][Full Text] [Related]
3. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
4. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography.
Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J
Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251
[TBL] [Abstract][Full Text] [Related]
5. SUBFOVEAL CHOROIDAL THICKNESS IN PAPILLITIS TYPE OF VOGT-KOYANAGI-HARADA DISEASE AND IDIOPATHIC OPTIC NEURITIS.
Maruko I; Iida T; Sugano Y; Go S; Sekiryu T
Retina; 2016 May; 36(5):992-9. PubMed ID: 26509220
[TBL] [Abstract][Full Text] [Related]
6. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease.
Fong AH; Li KK; Wong D
Retina; 2011 Mar; 31(3):502-9. PubMed ID: 21336069
[TBL] [Abstract][Full Text] [Related]
7. PREDICTIVE ROLE OF SWEPT SOURCE OCT ANGIOGRAPHY IN RELAPSING VOGT-KOYANAGI-HARADA DISEASE.
Interlandi E; Pellegrini F; Papayannis A; Latanza L; Pece A; Pavesio C
Retin Cases Brief Rep; 2023 Jul; 17(4):414-418. PubMed ID: 35880955
[TBL] [Abstract][Full Text] [Related]
8. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
9. Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography.
Invernizzi A; Mapelli C; Viola F; Cigada M; Cimino L; Ratiglia R; Staurenghi G; Gupta A
Retina; 2015 Mar; 35(3):525-31. PubMed ID: 25105317
[TBL] [Abstract][Full Text] [Related]
10. Changes of choroidal structure after corticosteroid treatment in eyes with Vogt-Koyanagi-Harada disease.
Egawa M; Mitamura Y; Akaiwa K; Semba K; Kinoshita T; Uchino E; Sonoda S; Sakamoto T
Br J Ophthalmol; 2016 Dec; 100(12):1646-1650. PubMed ID: 26906951
[TBL] [Abstract][Full Text] [Related]
11. Widefield Swept-Source OCTA in Vogt-Koyanagi-Harada Disease.
Vingopoulos F; Cui Y; Katz R; Le R; Zhu Y; Wang JC; Lu Y; Sobrin L; Miller JB
Ophthalmic Surg Lasers Imaging Retina; 2020 Jul; 51(7):407-412. PubMed ID: 32706899
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment.
Bolletta E; Gozzi F; Mastrofilippo V; Pipitone N; De Simone L; Croci S; Invernizzi A; Adani C; Iannetta D; Coassin M; Fontana L; Salvarani C; Cimino L
Ocul Immunol Inflamm; 2022 Aug; 30(6):1303-1308. PubMed ID: 33793383
[TBL] [Abstract][Full Text] [Related]
13. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease.
da Silva FT; Sakata VM; Nakashima A; Hirata CE; Olivalves E; Takahashi WY; Costa RA; Yamamoto JH
Br J Ophthalmol; 2013 Jan; 97(1):70-4. PubMed ID: 23099292
[TBL] [Abstract][Full Text] [Related]
14. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.
Tagawa Y; Namba K; Mizuuchi K; Takemoto Y; Iwata D; Uno T; Fukuhara T; Hirooka K; Kitaichi N; Ohno S; Ishida S
Br J Ophthalmol; 2016 Apr; 100(4):473-7. PubMed ID: 26261230
[TBL] [Abstract][Full Text] [Related]
15. Role of Swept source optical coherence tomography in management of acute Vogt-Koyanagi-Harada's disease.
Ganesh SK; Mistry S; Nair N
Indian J Ophthalmol; 2022 Jul; 70(7):2458-2463. PubMed ID: 35791133
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes.
Copete S; Flores-Moreno I; Montero JA; Duker JS; Ruiz-Moreno JM
Br J Ophthalmol; 2014 Mar; 98(3):334-8. PubMed ID: 24288394
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
Silpa-Archa S; Ittharat W; Chotcomwongse P; Preble JM; Foster CS
Curr Eye Res; 2021 Jul; 46(7):1010-1017. PubMed ID: 33215546
[No Abstract] [Full Text] [Related]
18. Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment.
Kawano H; Sonoda S; Yamashita T; Maruko I; Iida T; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):421-6. PubMed ID: 26847039
[TBL] [Abstract][Full Text] [Related]
19. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.
Hirooka K; Saito W; Namba K; Takemoto Y; Mizuuchi K; Uno T; Tagawa Y; Hashimoto Y; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):609-17. PubMed ID: 25619665
[TBL] [Abstract][Full Text] [Related]
20. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
